Exact Mass: 295.0955

Exact Mass Matches: 295.0955

Found 42 metabolites which its exact mass value is equals to given mass value 295.0955, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Citalopram aldehyde

1-(4-fluorophenyl)-1-(3-oxopropyl)-1,3-dihydro-2-benzofuran-5-carbonitrile

C18H14FNO2 (295.1009)


Citalopram aldehyde is a metabolite of citalopram. Citalopram is an antidepressant drug of the selective serotonin reuptake inhibitor (SSRI) class. It has U.S. Food and Drug Administration (FDA) approval to treat major depression, and is prescribed off-label for a number of anxiety conditions. (Wikipedia)

   

mebendazole

mebendazole

C16H13N3O3 (295.0957)


P - Antiparasitic products, insecticides and repellents > P02 - Anthelmintics > P02C - Antinematodal agents > P02CA - Benzimidazole derivatives D050258 - Mitosis Modulators > D050256 - Antimitotic Agents > D050257 - Tubulin Modulators D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000871 - Anthelmintics C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C250 - Antihelminthic Agent D000970 - Antineoplastic Agents > D050256 - Antimitotic Agents INTERNAL_ID 8534; CONFIDENCE standard compound CONFIDENCE standard compound; INTERNAL_ID 8534 CONFIDENCE standard compound; EAWAG_UCHEM_ID 3668 CONFIDENCE standard compound; INTERNAL_ID 1164 CONFIDENCE standard compound; INTERNAL_ID 1064

   

Mebendazole

(5-Benzoyl-1H-benzimidazol-2-yl)-carbamic acid methyl ester

C16H13N3O3 (295.0957)


Mebendazole is only found in individuals that have used or taken this drug. It is a benzimidazole that acts by interfering with carbohydrate metabolism and inhibiting polymerization of microtubules. [PubChem]Mebendazole causes degenerative alterations in the tegument and intestinal cells of the worm by binding to the colchicine-sensitive site of tubulin, thus inhibiting its polymerization or assembly into microtubules. The loss of the cytoplasmic microtubules leads to impaired uptake of glucose by the larval and adult stages of the susceptible parasites, and depletes their glycogen stores. Degenerative changes in the endoplasmic reticulum, the mitochondria of the germinal layer, and the subsequent release of lysosomes result in decreased production of adenosine triphosphate (ATP), which is the energy required for the survival of the helminth. Due to diminished energy production, the parasite is immobilized and eventually dies. P - Antiparasitic products, insecticides and repellents > P02 - Anthelmintics > P02C - Antinematodal agents > P02CA - Benzimidazole derivatives D050258 - Mitosis Modulators > D050256 - Antimitotic Agents > D050257 - Tubulin Modulators D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000871 - Anthelmintics C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C250 - Antihelminthic Agent D000970 - Antineoplastic Agents > D050256 - Antimitotic Agents

   

Nor-ketotifen

2-(piperidin-4-ylidene)-6-thiatricyclo[8.4.0.0³,⁷]tetradeca-1(14),3(7),4,10,12-pentaen-8-one

C18H17NOS (295.1031)


Nor-ketotifen is a metabolite of ketotifen. Ketotifen is a second-generation H1-antihistamine and mast cell stabilizer. It is most commonly sold in as a salt of fumaric acid, ketotifen fumarate, and is available in two forms. In its ophthalmic form, it is used to treat allergic conjunctivitis, or the itchy red eyes caused by allergies. In its oral form, it is used to prevent asthma attacks. Side effects include drowsiness, weight gain, dry mouth, irritability, and increased nosebleeds. (Wikipedia)

   

2-Methyl-3-(3-nitro-o-tolyl)-4(3H)-quinazolinone

2-methyl-3-(2-methyl-3-nitrophenyl)-3,4-dihydroquinazolin-4-one

C16H13N3O3 (295.0957)


   

Nepicastat

5-(aminomethyl)-1-(5,7-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)-2,3-dihydro-1H-imidazole-2-thione

C14H15F2N3S (295.0955)


   

nimetazepam

nimetazepam

C16H13N3O3 (295.0957)


D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives N - Nervous system > N05 - Psycholeptics > N05C - Hypnotics and sedatives > N05CD - Benzodiazepine derivatives D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018757 - GABA Modulators C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent D002491 - Central Nervous System Agents > D000927 - Anticonvulsants

   

6-(1-acetoxy-2-dihydroxy-propyl)-2-amino-3H,8H-pteridine-4,7-dione

6-(1-acetoxy-2-dihydroxy-propyl)-2-amino-3H,8H-pteridine-4,7-dione

C11H13N5O5 (295.0917)


   

6-(2-acetoxy-1-dihydroxy-propyl)-2-amino-3H,8H-pteridine-4,7-dione

6-(2-acetoxy-1-dihydroxy-propyl)-2-amino-3H,8H-pteridine-4,7-dione

C11H13N5O5 (295.0917)


   

Penipanoid A

Penipanoid A

C16H13N3O3 (295.0957)


A member of the class of benzoic acids that is benzoic acid substituted by a 1H-1,2,4-triazol-1-yl group at position 2 which in turn is substituted by a 4-hydroxybenzyl group at position 5. It has been isolated from Penicillium paneum.

   
   

N6-Formyl-adenosine

N6-Formyl-adenosine

C11H13N5O5 (295.0917)


   
   

(S)-malyl alpha-D-glucosaminide

GlcN-Mal;alpha-D-GlcN-L-Mal;malyl-D-glucosamine

C10H17NO9 (295.0903)


A D-glucosaminide having (S)-malyl as the anomeric substituent and alpha-configuration at the anomeric centre.

   
   

N-(2-Chlorobenzyl)-1-phenyl-2-propanamine hydrochloride (1:1)

N-(2-Chlorobenzyl)-1-phenyl-2-propanamine hydrochloride (1:1)

C16H19Cl2N (295.0894)


   

Dibenamine hydrochloride

Dibenamine hydrochloride

C16H19Cl2N (295.0894)


Dibenamine hydrochloride is a competitive and irreversible?adrenergic blocking agent and?is known to modify the pharmacological effects of epinephrine. Dibenamine hydrochloride cause a significant increase in the rate of destruction of I-epinephrine in the mouse[1][2].

   

Chlorothen

Chloropyrilene

C14H18ClN3S (295.091)


C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist

   

9-(3,4-dichlorophenyl)-3-azaspiro[5.5]undec-9-ene

9-(3,4-dichlorophenyl)-3-azaspiro[5.5]undec-9-ene

C16H19Cl2N (295.0894)


   

4-aminobenzoic acid,(2,5-dioxoimidazolidin-4-yl)urea

4-aminobenzoic acid,(2,5-dioxoimidazolidin-4-yl)urea

C11H13N5O5 (295.0917)


   

Azidamfenicol

Azidamfenicol

C11H13N5O5 (295.0917)


S - Sensory organs > S01 - Ophthalmologicals > S01A - Antiinfectives > S01AA - Antibiotics C254 - Anti-Infective Agent > C258 - Antibiotic

   
   

N-BUTYL-3-METHYLPYRIDINIUM HEXAFLUOROPHOSPHATE

N-BUTYL-3-METHYLPYRIDINIUM HEXAFLUOROPHOSPHATE

C10H16F6NP (295.0924)


   

2-diethoxyphosphoryl-1-(1H-indol-3-yl)ethanone

2-diethoxyphosphoryl-1-(1H-indol-3-yl)ethanone

C14H18NO4P (295.0973)


   

1-Butyl-4-methylpyridinium hexafluorophosphate

1-Butyl-4-methylpyridinium hexafluorophosphate

C10H16F6NP (295.0924)


   

N-Benzyl-N,N,N-trimethylammonium hexafluorophosphate

N-Benzyl-N,N,N-trimethylammonium hexafluorophosphate

C10H16F6NP (295.0924)


   
   

3-(3-Chloropropyl)-1,3-dihydro-7,8-dimethoxy-2H-3-benzazepin-2-one

3-(3-Chloropropyl)-1,3-dihydro-7,8-dimethoxy-2H-3-benzazepin-2-one

C15H18ClNO3 (295.0975)


   

4-CHLORO-5-FORMYL-3,6,6-TRIMETHYL-6,7-DIHYDRO-1H-INDOLE-2-CARBOXYLIC ACID ETHYL ESTER

4-CHLORO-5-FORMYL-3,6,6-TRIMETHYL-6,7-DIHYDRO-1H-INDOLE-2-CARBOXYLIC ACID ETHYL ESTER

C15H18ClNO3 (295.0975)


   

Nepicastat

Nepicastat

C14H15F2N3S (295.0955)


C471 - Enzyme Inhibitor

   

Cytidine5-monophosphate

Cytidine5-monophosphate

C14H15F2N3S (295.0955)


   

1-[(E)-2,3-Dihydro-1,4-benzodioxin-6-ylmethylideneamino]-3-(2-methoxyethyl)thiourea

1-[(E)-2,3-Dihydro-1,4-benzodioxin-6-ylmethylideneamino]-3-(2-methoxyethyl)thiourea

C13H17N3O3S (295.0991)


   

2-[[4-Amino-2-(ethylamino)-5-thiazolyl]-phenylmethylidene]propanedinitrile

2-[[4-Amino-2-(ethylamino)-5-thiazolyl]-phenylmethylidene]propanedinitrile

C15H13N5S (295.0892)


   

3-[(2-Fluorophenyl)methyl]-7-(1-imidazolyl)triazolo[4,5-d]pyrimidine

3-[(2-Fluorophenyl)methyl]-7-(1-imidazolyl)triazolo[4,5-d]pyrimidine

C14H10FN7 (295.0982)


   

2-hydroxy-N-[(1-methyl-2-oxo-3-indolylidene)amino]benzamide

2-hydroxy-N-[(1-methyl-2-oxo-3-indolylidene)amino]benzamide

C16H13N3O3 (295.0957)


   

5-(2-Furanylmethylamino)-2-(4-methoxyphenyl)-4-oxazolecarbonitrile

5-(2-Furanylmethylamino)-2-(4-methoxyphenyl)-4-oxazolecarbonitrile

C16H13N3O3 (295.0957)


   

2-Methoxy-4-(methylthio)benzoic acid [2-(cyclopropylamino)-2-oxoethyl] ester

2-Methoxy-4-(methylthio)benzoic acid [2-(cyclopropylamino)-2-oxoethyl] ester

C14H17NO4S (295.0878)


   

3-[(2,4-dihydroxybenzylidene)amino]-2-methyl-4(3H)-quinazolinone

3-[(2,4-dihydroxybenzylidene)amino]-2-methyl-4(3H)-quinazolinone

C16H13N3O3 (295.0957)


   

7-Chloro-N-[(E)-(2-methylphenyl)methylideneamino]quinolin-4-amine

7-Chloro-N-[(E)-(2-methylphenyl)methylideneamino]quinolin-4-amine

C17H14ClN3 (295.0876)


   

Hexanal O-[(pentafluorophenyl)methyl]oxime

Hexanal O-[(pentafluorophenyl)methyl]oxime

C13H14F5NO (295.0995)


   

Citalopram aldehyde

Citalopram aldehyde

C18H14FNO2 (295.1009)


   

2'-O,4'-C-Methyleneguanosine

2'-O,4'-C-Methyleneguanosine

C11H13N5O5 (295.0917)


2′-O,4′-C-Methyleneguanosine (LNA-G) is a reverse guanine analogue, where LNA (locked nucleic acid) is a nucleic acid analogue. LNA modification can be used in a variety of applications such as effective binding affinity to complementary sequences and greater nuclease resistance than natural nucleotides, offering great potential for applications in disease diagnosis and research. LNA-G is also available via KOD DNA polymerase, which allows the integration of LNA-G nucleotides into the DNA strand[1][2].